Online citations, reference lists, and bibliographies.
← Back to Search

Immuno-subtyping Of Breast Cancer Reveals Distinct Myeloid Cell Profiles And Immunotherapy Resistance Mechanisms

I. S. Kim, Y. Gao, Thomas Welte, Hai Wang, Jia-sen Liu, M. Janghorban, Kuanwei Sheng, Yichi Niu, A. Goldstein, N. Zhao, I. Bado, Hin-Ching Lo, M. Toneff, Tuan Nguyen, W. Bu, Weiyu Jiang, J. Arnold, Franklin Gu, J. He, D. Jebakumar, K. Walker, Y. Li, Q. Mo, T. Westbrook, Chenghang Zong, A. Rao, A. Sreekumar, J. Rosen, X. Zhang
Published 2019 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Cancer-induced immune responses affect tumour progression and therapeutic response. In multiple murine models and clinical datasets, we identified large variations of neutrophils and macrophages that define ‘immune subtypes’ of triple-negative breast cancer (TNBC), including neutrophil-enriched (NES) and macrophage-enriched subtypes (MES). Different tumour-intrinsic pathways and mutual regulation between macrophages (or monocytes) and neutrophils contribute to the development of a dichotomous myeloid compartment. MES contains predominantly macrophages that are CCR2-dependent and exhibit variable responses to immune checkpoint blockade (ICB). NES exhibits systemic and local accumulation of immunosuppressive neutrophils (or granulocytic myeloid-derived suppressor cells), is resistant to ICB, and contains a minority of macrophages that seem to be unaffected by CCR2 knockout. A MES-to-NES conversion mediated acquired ICB resistance of initially sensitive MES models. Our results demonstrate diverse myeloid cell frequencies, functionality and potential roles in immunotherapies, and highlight the need to better understand the inter-patient heterogeneity of the myeloid compartment. Kim et al. demonstrate neutrophil- and macrophage-enriched subtypes in triple-negative breast cancer and how these immune profiles affect therapeutic responses to immune checkpoint blockade.
This paper references
Describe the gating strategy used for all relevant experiments, specifying the preliminary FSC/SSC gates of the starting cell population
:100, clone 30-F11, Tonbo, cat # 75-0451-U100)
10.1038/ni.2419
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages
E. Gautier (2012)
10.1016/J.IMMUNI.2005.10.001
Macrophage polarization comes of age.
A. Mantovani (2005)
10.1186/s13059-016-1028-7
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li (2016)
10.1093/jnci/djw144
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.
M. Iglesia (2016)
10.1083/jcb.201006052
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
V. Papayannopoulos (2010)
10.1016/j.it.2010.10.002
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function.
T. Condamine (2011)
10.1073/pnas.1015855107
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
M. Kowanetz (2010)
10.1073/pnas.1424927112
Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils
Amy-Jo Casbon (2015)
All cases were triple negative (ER-PR-HER2-), Lymph node status at the time of presentation
10.1242/dmm.025239
Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers
A. Pfefferle (2016)
Alexa Fluor 488-conjugated donkey anti-rat secondary antibody (1:250, Jackson ImmunoResearch, cat # 712-546-153)
10.1186/gb-2013-14-4-r34
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis
S. Nagalla (2013)
10.1073/pnas.0506580102
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Aravind Subramanian (2005)
10.1038/nature10983
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
C. Curtis (2012)
10.1038/nature19834
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda (2016)
The specific samples used in this study are listed in Supplementary Table 2a
:100, ebioscience
Gr1-Pe
10.1200/JCO.2007.14.4287
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
P. Nguyen (2008)
10.4049/jimmunol.1300194
TSG-6 Inhibits Neutrophil Migration via Direct Interaction with the Chemokine CXCL8
Douglas P Dyer (2014)
10.1038/nm.3909
The prognostic landscape of genes and infiltrating immune cells across human cancers
A. Gentles (2015)
10.1126/science.1203486
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
R. Schreiber (2011)
10.1038/nmeth.3337
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman (2015)
10.1016/j.ccr.2009.06.017
Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.
Z. Fridlender (2009)
10.1158/0008-5472.CAN-16-3292
Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas.
Anushka Dongre (2017)
10.1016/j.cell.2010.03.014
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian (2010)
Pollard JW Microenvironmental regulation of metastasis
J A Joyce (2009)
10.1038/nri2506
Myeloid-derived suppressor cells as regulators of the immune system
D. Gabrilovich (2009)
10.1158/2159-8290.CD-12-0476
Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1.
R. Catena (2013)
Gene expression profiles of TAN, GMDSC and normal neutrophils. Data available from GEO
Authentication No cell line authentication was performed
10.1186/1471-2164-14-632
An expression atlas of human primary cells: inference of gene function from coexpression networks
N. Mabbott (2013)
10.1158/1078-0432.CCR-13-3368
Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer
M. Iglesia (2014)
Mycoplasma contamination All cell lines except PyMT-M-ICBR were tested for mycoplasma contamination and were confirmed negative
10.1016/S1074-7613(02)00424-7
G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood.
C. Semerad (2002)
Flow Cytometry Plots Confirm that: The axis labels state the marker and fluorochrome used (e.g. CD4-FITC)
10.1038/nature14282
IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
S. Coffelt (2015)
10.1073/pnas.1018862108
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells
J. Herschkowitz (2011)
10.2217/imt.11.116
Macrophages in cancer and infectious diseases: the 'good' and the 'bad'.
C. Porta (2011)
10.1158/0008-5472.CAN-07-5644
Subtypes of breast cancer show preferential site of relapse.
M. Smid (2008)
gene set variation analysis for microarray and RNA-Seq data
S Hänzelmann (2013)
10.1016/j.immuni.2012.08.022
The transcription factor Jdp2 controls bone homeostasis and antibacterial immunity by regulating osteoclast and neutrophil differentiation.
K. Maruyama (2012)
10.1593/NEO.07871
Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response.
Jessica C. Pahler (2008)
10.1111/joim.12084
Breast cancer as a systemic disease: a view of metastasis
A. Redig (2013)
Transgenic Polyoma middle-T mice model premalignant mammary disease.
J. Maglione (2001)
10.1158/1078-0432.CCR-15-1434
Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
Y. Lou (2016)
Gabrilovich DI Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
T Condamine (2011)
biologically independent mice per group denoted by different color. Data are shown as mean ± S.D. P values were computed by two-sided Student's t-tests
manuscript; available in PMC
10.1371/journal.pone.0031524
Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal Neutrophils
Z. Fridlender (2012)
10.1007/s10555-016-9643-z
One microenvironment does not fit all: heterogeneity beyond cancer cells
I. S. Kim (2016)
10.1038/nri3175
Coordinated regulation of myeloid cells by tumours
D. Gabrilovich (2012)
10.1016/j.ccr.2009.12.020
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
R. Verhaak (2010)
Hakkim A & Zychlinsky A Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
V Papayannopoulos (2010)
10.1016/j.devcel.2010.05.012
Tumors as organs: complex tissues that interface with the entire organism.
M. Egeblad (2010)
10.1038/ncb1722
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
P. A. Gregory (2008)
10.1172/JCI45014
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
B. Lehmann (2011)
Ly6G-PerCPcy5.5 (1:100, clone 1A8, Tonbo, cat # 65-1276-U100)
Integrating Immunity's Roles in Cancer Suppression and Promotion. Science (80
R D Schreiber (2011)
Markowetz F & Caldas C Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H R Ali (2016)
10.1038/nature16140
Neutrophils support lung colonization of metastasis-initiating breast cancer cells
S. Wculek (2015)
10.1038/nrc2618
Microenvironmental regulation of metastasis
J. Joyce (2009)
10.1074/jbc.C800074200
The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2*
M. Korpal (2008)
10.1007/s00262-017-1963-5
Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease
Colleen S Netherby (2017)
Envision Labeled Polymer-HRP anti-rabbit (Dako, code K4002)
Jianming Xu's lab at Baylor College of Medicine
Metastatic behavior of breast cancer
H Kennecke (2010)
10.1371/journal.pmed.1002194
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. R. Ali (2016)
10.1172/JCI28828
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.
Giovanna Gallina (2006)
10.1016/j.cell.2017.09.028
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
N. Riaz (2017)
10.1038/embor.2008.74
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike C. Burk (2008)
10.1186/1471-2105-14-7
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Hänzelmann (2012)
Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
L A Carey (2006)
10.1016/j.ccr.2012.02.022
Accessories to the crime: functions of cells recruited to the tumor microenvironment.
D. Hanahan (2012)
10.1200/JCO.2009.25.9820
Metastatic behavior of breast cancer subtypes.
H. Kennecke (2010)
10.1038/nature20554
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
O. D. Henau (2016)
10.1038/s41586-019-1450-6
Loss of p53 triggers Wnt-dependent systemic inflammation to drive breast cancer metastasis
M. Wellenstein (2019)
Macrophage depletion: anti-CSF1 (clone 5A1, 0.5 mg) Control animals received an equal amount of isotype-matched antibodies (mouse IgG2b (clone MPC-11), rat IgG2a (clone 2A3)
Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers)
10.1016/j.ccr.2011.08.012
Tumor entrained neutrophils inhibit seeding in the premetastatic lung.
Z. Granot (2011)
10.1073/pnas.0608607103
Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models
Zhijun Du (2006)
10.1002/eji.200839120
IL-17-producing gammadelta T cells.
R. O’Brien (2009)
Wculek SK & Malanchi I Neutrophils support lung colonization of metastasis-initiating breast cancer cells
(2015)
10.1186/s12915-016-0269-y
The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states
M. Toneff (2016)
10.1038/nature04186
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
R. Kaplan (2005)
:100, clone RA3-6B2, Biolegend, cat # 25-0452-U100), CD3e-PerCPcy5.5 (1:100, clone 145-2C11, Tonbo, cat # 65-0031-U100)
Alexa Fluor 594-conjugated goat anti-rabbit secondary antibody (1:250, Jackson ImmunoResearch
F4/80-FITC (1:200, clone BM8.1, Tonbo, cat # 35-4801-U500), I-A/I-E-BV510 (1:100, clone M5/114.15.2, Biolegend, cat # 107635)
10.1001/JAMA.295.21.2492
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
L. Carey (2006)
Commonly misidentified lines (See ICLAC register) No cell lines used in this study were found in the Register of Misidentified Cell Lines maintained by ICLAC
Pollard JW Macrophage diversity enhances tumor progression and metastasis
B Z Qian (2010)
10.1073/pnas.1004900107
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
J. Taube (2010)
10.1084/jem.20062512
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
S. Deaglio (2007)
All plots are contour plots with outliers or pseudocolor plots. A numerical value for number of cells or percentage
IL-17-producing ɣδ T cells and neutrophils conspire to promote breast cancer metastasis
Coffelt (2015)
10.1038/ncomms12150
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
V. Bronte (2016)
10.1038/nature21724
Mutual Regulation of Tumour Vessel Normalization and Immunostimulatory Reprogramming
Lin Tian (2017)
10.1016/j.cell.2016.02.065
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
W. Hugo (2016)
10.1038/35021093
Molecular portraits of human breast tumours
C. Perou (2000)
Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors.
M. Sitkovsky (2005)
10.1007/s00262-005-0048-z
Role Of Immature Myeloid Cells in Mechanisms of Immune Evasion In Cancer
S. Kusmartsev (2005)
10.1126/scitranslmed.aag1711
Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
J. Park (2016)
10.1038/ncb3379
Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation.
T. Welte (2016)
All animal experiments were conducted in accordance with a protocol approved by Institutional Animal Care and Use Committee at Baylor College of Medicine
10.1038/nm.3337
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
S. Pyonteck (2013)



This paper is referenced by
10.21037/atm.2020.03.194
Molecular subtypes and precision treatment of triple-negative breast cancer.
Songli Zhao (2020)
10.7150/thno.44523
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
Alison K. Esser (2020)
10.3389/fimmu.2020.01778
Neutrophils: Orchestrators of the Malignant Phenotype
B. E. Hsu (2020)
10.1038/s41523-020-00197-2
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
A. Marra (2020)
10.1158/2326-6066.CIR-19-0786
Immune Escape during Breast Tumor Progression
C. R. Gil del Alcazar (2020)
10.3389/fonc.2020.575657
Translating Preclinical Research for Exercise Oncology: Take It to the VO2max
D. Lamkin (2020)
10.1038/s41556-020-0491-2
Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis
J. Nishida (2020)
10.1038/s41556-019-0386-2
Tumours pick the path to cancer inflammation
L. Maiorino (2019)
10.21037/atm.2020.02.51
RNA-sequencing and microarray data mining revealing: the aberrantly expressed mRNAs were related with a poor outcome in the triple negative breast cancer patients.
Hong-Jun Fei (2020)
10.1002/ijc.33009
Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple‐negative breast cancer
S. Zheng (2020)
10.1016/j.smim.2020.101408
Prognostic significance of tumor-associated macrophages: past, present and future.
Nina Cortese (2020)
10.7150/thno.46176
Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer
Dongqiang Zeng (2020)
10.21037/TCR.2020.01.52
Antitumor effects of targeting myeloid-derived suppressive cells
D. Zeng (2020)
10.1002/JLB.4MR0820-011R
Brief review on the roles of neutrophils in cancer development.
Wang Long (2020)
10.1007/s11427-020-1714-8
Triple-negative breast cancer: new treatment strategies in the era of precision medicine
S. Wu (2020)
10.1080/2162402x.2020.1802979
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses
Amanda J Oliver (2020)
10.1101/2020.11.02.365288
In vivo optical metabolic imaging of long-chain fatty acid uptake in orthotopic models of triple negative breast cancer
Megan C. Madonna (2020)
10.3390/cancers11101569
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
Maria Laura De Angelis (2019)
10.3390/cancers12051076
Tumor-Infiltrating CD8 T Cells Predict Clinical Breast Cancer Outcomes in Young Women
Yong Won Jin (2020)
10.1038/s41467-020-18916-5
Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma
Zhaohui Chen (2020)
10.1186/s12865-020-0337-5
The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer
Andrea J. Luker (2020)
10.3389/fimmu.2020.590794
Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer
Justin T Gibson (2020)
10.3389/fimmu.2020.01590
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
Elisa Peranzoni (2020)
10.2147/OTT.S240973
Construction and Analysis of a Long Non-Coding RNA-Associated Competing Endogenous RNA Network Identified Potential Prognostic Biomarkers in Luminal Breast Cancer
Zhou Jiang (2020)
10.1002/cti2.1108
CD163+ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes
R. Ramos (2020)
10.3389/fimmu.2020.01779
A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment
W. Zhang (2020)
10.1002/jcp.29898
Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm‐derived immune scores
Zhi-Bin Ke (2020)
10.3390/cancers12092686
Loss of Proprotein Convertase Furin in Mammary Gland Impairs proIGF1R and proIR Processing and Suppresses Tumorigenesis in Triple Negative Breast Cancer
Zong-sheng He (2020)
10.1016/j.canlet.2020.05.001
Loss of the proprotein convertase Furin in T cells represses mammary tumorigenesis in oncogene-driven triple negative breast cancer.
Zong-sheng He (2020)
10.3389/fimmu.2020.565165
Neutrophil: A New Player in Metastatic Cancers
Mengyue Wu (2020)
10.3390/cancers12020352
A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer
L. Liu (2020)
10.1038/s41598-020-70788-3
Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis
Lea Monteran (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar